Riva Gold
Riva Gold is an oral anticoagulant formulation containing Rivaroxaban, designed to help prevent and treat thromboembolic disorders. It works by selectively inhibiting Factor Xa, reducing the risk of blood clot formation while maintaining predictable anticoagulant action. Riva Gold is widely prescribed for the prevention of stroke in atrial fibrillation, treatment and prevention of deep vein thrombosis (DVT), and pulmonary embolism (PE). With once-daily dosing and reliable bioavailability, Riva Gold offers improved patient compliance. Manufactured under stringent quality standards, it ensures safety, consistency, and dependable clinical outcomes.